Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2021-06-24 Major Shareholding Noti…
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'Major shareholder announcement' and details a change in the holding percentage of a specific entity (Aescap Venture Management B.V) falling below the 5% threshold, referencing the Danish Capital Markets Act. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2021-06-24 English
Major shareholder announcement
Major Shareholding Notification Classification · 100% confidence The document is titled 'Major shareholder announcement' and explicitly states it is a notification pursuant to the Danish Capital Markets Act regarding changes in shareholding levels (The Goldman Sachs Group, Inc. crossing the 5% threshold). This aligns perfectly with the definition for Major Shareholding Notification (MRQ).
2021-06-23 English
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Major shareholder announcement" and details changes in the aggregate holding of shares and voting rights by The Goldman Sachs Group, Inc., crossing ownership thresholds (5.58% and then less than 5%). This directly corresponds to the definition of a Major Shareholding Notification, which is categorized as 'MRQ'. The document length is short (1753 chars), but the content is the announcement itself, not a notice about another report, so the RPA/RNS fallback is not necessary.
2021-06-23 English
Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick disease type C
Regulatory Filings Classification · 95% confidence The document is a company announcement from Orphazyme regarding a regulatory update (Complete Response Letter) from the FDA. It details the impact of this regulatory decision on the company's financial outlook and announces upcoming conference calls to discuss these developments. While it mentions financial figures, it is not a formal financial report, but rather a regulatory announcement of material information. It fits best under the 'Regulatory Filings' (RNS) category as it is a general corporate announcement regarding regulatory and operational updates.
2021-06-18 English
Regulatory Filings 2021
Regulatory Filings Classification · 98% confidence The document is titled 'Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick disease type C' and is issued as a 'Company announcement' on June 18, 2021. It details a regulatory event (receiving a Complete Response Letter from the FDA) and provides an updated financial outlook for 2021. It also announces conference calls to discuss this information. This structure—a formal announcement of significant corporate/regulatory news, including financial impact and investor call details—is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not the full quarterly report (IR) or the full annual report (10-K), and it focuses on the immediate financial and regulatory impact following a key event, it aligns best with an Earnings Release (ER), which often includes key financial guidance changes. However, because the core content is a specific regulatory update (FDA CRL) that necessitates a financial outlook change, and it is presented as a general company announcement, it could also be classified as a Regulatory Filing (RNS). Given the inclusion of specific financial guidance changes (operating expenses, loss, cash position) and the announcement of investor calls to discuss the results/update, ER is a strong candidate. If the document were purely a regulatory update without the specific financial outlook revision, RNS would be better. Since it contains the immediate financial consequences of the regulatory event, ER is the most precise fit among the options that cover periodic results/updates.
2021-06-18 English
Major shareholder announcement
Major Shareholding Notification Classification · 100% confidence The document is a formal company announcement regarding a change in shareholding levels, specifically noting that Sunstone Life Science Ventures Fund II K/S now holds less than 5% of the company's share capital. This falls under the definition of a Major Shareholding Notification (MRQ), which tracks changes in significant ownership thresholds.
2021-06-15 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.